Dr James Woody discusses off-patent indications for anti-TNF to address unmet patient needs in pain, inflammation and beyond. The pro-inflammatory cytokine tumour necrosis factor (TNF) supports tissue homeostasis throughout the body, regulating its production and survival and apoptosis of cells. Inflammation and fibrosis are hallmarks of many clinical disorders. It was discovered that inflammatory diseases […]

Leen Kawas is the President and CEO of Athira Pharma. Read the Q&A below to learn more about why she chose to study Alzheimer’s and how she co-founded Athira. Today, I am the president and CEO of Athira Pharma, a company that I co-founded after my graduate studies, focused on a new approach to Alzheimer’s […]

Tonix Pharmaceuticals is opening an early-stage antiviral asset deal with OyaGen as the pair targets COVID-19. The research and license pact, financials of which were not made public, focuses on the antiviral inhibitor of SARS-CoV-2, TNX-3500 (aka sangivamycin, formerly OYA1), which Tonix believes can hit back against the pandemic virus and “potentially other viral disorders.” […]